Tata group to launch India’s first low-cost Covid-19 test ‘Feluda’
By Administrator_India Capital Sands The Drugs Controller General of India has approved of the commercial launch of ‘Feluda’, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Covid-19 test, the Council of Scientific and Industrial Research (CSIR) said recently. This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of […]